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ABSTRACT 
Hyperbaric oxygen therapy (HBO) is defined as the inhalation of 100% oxygen inside a hyperbaric chamber 
that is pressurized to greater than 1 atmosphere (Atm). Typical HBO regimens use 1.5 to 2.5 Atm pressure 
for durations of 30 to 90 minutes, repeated multiple times. The time between and the total number of 
repeat sessions varies widely. The effectiveness of hyperbaric oxygen therapy for treatment of some 
diseases such as intravascular emboli, decompression sickness, anaerobic infections, CO poisoning was 
confirmed. For some diseases, such as traumatic brain injuries, the effectiveness of hyperbaric oxygen 
therapy as described by investigators is controversial. Chinese authors have reported many articles 
regarding treatment of neonatal hypoxia with hyperbaric oxygen therapy, but in other points of the world, 
this depth of experience does not exist. Recently, some other diseases, such as purpura fulminans, and 
pancreatitis, have been treated by hyperbaric oxygen therapy. In conclusion, if equipment for hyperbaric 
oxygen therapy is available, many patients will benefit by this method of treatment. 
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INTRODUCTION 
Hyperbaric oxygen therapy (HBO) is defined as the 
inhalation of 100% oxygen inside a hyperbaric chamber 
that is pressurized to greater than 1 atmosphere (Atm). 
Typical HBO regimens use 1.5 to 2.5atm pressure for 
durations of 30 to 90 minutes, repeated multiple times. 
The elevated pressure of oxygen in these chambers leads 
to patients showing elevated arterial PO2 and thus 
improvement of ischemic conditions. The time between 
and the total number of repeat sessions varies widely in 
studies (1). 
Hemoglobin and nitric oxide independently fulfill diverse 
and complex physiological roles in the body; together 
they subtly modulate microvascular perfusion in 
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response to second-by-second changes in local metabolic 
demand, contributing to hypoxic vasodilation (2). By 
increasing tissue PO2 hyperbaric oxygen therapy reverses 
this phenomenon and induces vasoconstriction by 
inactivating nitric oxide as a result of increased 
production of superoxide (3.4). 
Venous or Arterial Gas embolism 
Gas embolism is well described in the medical literature 
and nearly always reported as an iatrogenic 
complication, related to surgery or following trauma. It 
has been associated with positive pressure mechanical 
ventilation, the insertion (and removal) of central lines 
and empty IV infusion set-ups (5,6). It is a known 
complication of cardiac surgery with an incidence of 
approximately 0.1%, whether following bypass pump 
failure or by the introduction of gas in the surgical field. 
Other described sources of gas embolism include 
ingestion or colonic irrigation with hydrogen peroxide, 
and inhalation of pressurized helium. In the gynecologic 
literature, gas embolism is extensively described as 
occurring when air is introduced into venous plexuses of 
the uterus; for example, during douching, illegal 
abortion, urogenital sex during pregnancy, labor and 
delivery, laparoscopy, or hysteroscopy with CO2 laser (7). 
Lastly, it has been increasingly recognized as a 
complication of serious chest trauma, presumably 
through the creation of aero-vascular fistulas (8). 
The signs and symptoms of gas emboli depend on the 
amount, nature, and end-position of the introduced gas. 
Diagnosis is often presumptive, with suggestive signs and 
symptoms accompanied by a portal of gas entry. Small 
emboli in skeletal muscle or visceral vessels are usually 
well tolerated (7). Cerebral, coronary, and pulmonary 
emboli, however, can result in serious morbidity and 
mortality. Cerebral embolisms may cause headaches, 
visual disturbances, altered mentation, weakness, 
sensory defects, seizures, respiratory arrest, or death. 
Coronary emboli can cause dysrhythmias, hypotension, 
and myocardial infarction, whereas pulmonary gas 
emboli may lead to hypoxia, hypercapnia, and acute 
respiratory distress syndrome (ARDS) (3,9). Air in the 
microcirculation can lead to disseminated intravascular 
coagulation (DIC), tissue ischemia, and gastrointestinal 
mucosal damage. Physical examination may reveal a “mill 
wheel” murmur on cardiac auscultation, skin marbling, 
blanching of the nail beds, pallor of the mucous 
membranes, or more rarely, air bubbles in the retinal 
arteries. Echocardiography can be a very useful adjunct 
in diagnosing intracardiac gas emboli. A head CT scan 
may reveal subtle changes in cerebral arterial gas 
embolism, but is not routinely reliable, especially in early 
diagnosis (10,11). In general, the universally lethal 
volume of embolized gas in an adult is not known, but is 
estimated at 200–300 mL of introduced air. 
Administration of 100% oxygen, crystalloids infusion, and 
supportive care are the mainstays of gas embolism 
therapy. In an effort to decrease cerebral emboli, 
Trendelenburg positioning is often recommended, as it is 
thought to decrease the volume of gas “rising” to the 
cerebral circulation (4,13). More recently, others have 
recommended flat supine positioning, stressing that 
Trendelenberg positioning is not only unhelpful in 
preventing the propulsion of bubbles into cerebral 
arteries, but may actually aggravate cerebral edema 
(7,13,14). In aiming to reduce cerebral edema and 
damage, corticosteroids were previously, but no longer 
routinely recommended, though various studies have 
found intravenous lidocaine therapy to be helpful (7,15). 
Closed chest cardiac massage, in the setting of 
cardiopulmonary arrest, may also help mechanically with 
the breakup and dissolution of embolic gas bubbles. 
Symptomatic cerebral or coronary air emboli, as 
suggested in this case, necessitate serious consideration 
of hyperbaric oxygen therapy (13,16,17). The rationale is 
based on principles of gas physiology, and this is clinically 
reinforced. Room air emboli are composed primarily of 
oxygen and nitrogen. At atmospheric pressure, oxygen 
readily reabsorbs into solution, but nitrogen remains 
insoluble and in potentially embolic bubble form. Both 
high-flow oxygen and hyperbaric oxygen therapy are 
standard treatments that decrease the size and 
absorption time of excess bloodstream nitrogen. 
“Hyperoxygenation” works not only to oxygenate end 
organs, but also facilitates the absorption of residual 
nitrogen. Room air is composed of 80% nitrogen and 20% 
oxygen, but as the oxygen tension is increased in the 
blood, the “O2 window” for nitrogen removal is widened. 
Hyperoxygenation, increasing blood oxygen tension, 
facilitates nitrogen removal from embolic bubbles by 
steepening nitrogen bubbles’ downstream gradient into 
hyperoxygenated (i.e., nitrogen-poor) blood. Clinically, a 
4-mm diameter nitrogen bubble disappears in 560 min 
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on room air, or 56 min on 100% oxygen. Additionally, 
hyperbaric pressure physically compresses embolic 
bubbles. Any gas volume varies inversely with ambient 
pressure (i.e., Boyle’s law), thus, at three atmospheres of 
pressure, a bubble’s volume would be but one-third its 
volume at sea level 
Although no formal trials support the use of hyperbaric 
oxygen in air embolism, well-established 
pathophysiology and extensive successful clinical 
experience justify its use as the primary treatment (18). 
Predictably, the efficacy of hyperbaric therapy is 
inversely proportional to time elapsed since the embolic 
event. Benefit is reported when therapy begins several 
hours after the onset of air embolism (19). 
Neonatal hypoxia 
The Chinese medical literature may be a rich source of 
evidence to inform clinical practice and other systematic 
reviews have also concluded that treatment with 
hyperbaric oxygen possibly reduces mortality and 
neurological sequels in term neonates with hypoxic-
ischemic encephalopathy (20). 
For example, in their study Liu et al. concluded that early 
HBO treatment with 2 atmospheres resulted in a 
protective effect against hypoxic-ischemic brain damage-
induced long-term brain morphological and histological 
deficits and spatial learning and memory disability (21). 
Additionally, Calvert et al. (22) reported that hyperbaric 
oxygen (HBO) could be a treatment for neonatal hypoxia-
ischemia in a neonatal rat model and could prevent brain 
injury. In that study, HBO was administered in a chamber 
for 1 hour at 3 atm (atmospheres), 1 hour after hypoxia 
exposure. Results suggested that HBO, as a single 
therapy, is able to attenuate hypoxia-ischemia brain 
insult and offer neuroprotectivity. The HBO reduced 
neuronal injury with much less atrophy and apoptosis of 
immature neurons, resulting in further improvement of 
sensorimotor function of neonatal brain. 
Cerebral ischemia 
Clinical and experimental evidence suggests that a 
localized decrease in oxygen brain tissue availability 
contributes to the neurological deficit in patients with 
cerebrovascular disease (CVD) who also present with 
frontal leukoaraiosis (LA) (periventricular hypodensity on 
CT scan) and lacunar infarcts. In their study, Vila et al. 
(23) compared selected patients with symptomatic CVD, 
LA and lacunar infarcts who received daily exposures to 
hyperbaric oxygen of 45 min for 10 days with a control of 
similar patients treated with hyperbaric air. They 
concluded that there was a statistically significant 
improvement in all scales for the HBO2 group compared 
with the placebo group. Neurological improvement 
persisted in the majority of patients in the HBO group for 
up to 6 months. Repetition of the HBO2 protocol in 9 
patients in whom symptoms recurred after 6 months 
resulted in improvement of symptoms. 
The effectiveness of both normobaric hyperoxia and HBO 
in experimental transient focal ischemia has been shown 
by the majority of experimental studies (24–26). In the 
majority of clinical strokes, however, the occluded vessel 
fails to reopen rapidly (26)—a setting that is only 
appropriately reflected in permanent ischemia models. 
Velktkamp et al. (27) reported that HBO significantly 
reduced histological infarct size at 24 h. In their study, 48 
Wistar rats underwent filament occlusion of the middle 
cerebral artery (MCAO). Forty minutes after MCAO, the 
rats were placed in an HBO chamber and breathed either 
100% O2 at 3.0 Atm absolute or at 1.0 Atm for 1 h. 
Diffusion, perfusion and T2-weighted MR-images were 
obtained after 15 min and 3, 6 and 24 h of reperfusion. 
The researchers found that high-dose HBO therapy has 
an immediate protective effect on the brain that is 
superior to normobaric oxygen. 
Another study by Veltkamp et al. (28) provides several 
new findings. First, both normobaric hyperoxia and HBO 
therapy reduced infarct volume in a cortical permanent 
ischemia model. Remarkably, HBO provided significantly 
larger protection than normobaric hyperoxia in animal 
models when started within 120 min after occlusion of 
the middle cerebral artery. Repeated HBO treatment 
courses on subsequent days had no additional effect. In 
contrast, in filament-induced permanent subcortical and 
cortical ischemia, normobaric hyperoxia and HBO were 
ineffective, whereas HBO reduced infarct size compared 
to normobaric hyperoxia in transient filament occlusion 
of the middle cerebral artery. 
Traumatic brain injury 
Use of hyperbaric oxygen therapy (HBO) to treat 
traumatic brain injury is controversial, with implications 
for clinicians, patients, and health care systems. HBO is 
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used to treat patients with traumatic brain injury at some 
hyperbaric centers, but it is not widely accepted as 
effective for this indication. The potential mechanism of 
action of HBO in treating traumatic brain injury has not 
been fully elucidated. Its use in traumatic brain injury is 
based on the theory that damaged cells are in the 
ischemic penumbra (the border between healthy and 
damaged brain tissue), which may have the potential to 
be recovered (29,30). Improving oxygen availability to 
these cells may stimulate them to function normally, 
reactivating them metabolically or electrically, ultimately 
resulting in angiogenesis and other signs of healing (30). 
However, the potential for recovery may be diminished 
as the time postinjury increases (30). This theory is 
controversial, even though there is evidence that 
secondary ischemia and oxygen deficiency are important 
mechanisms of cell death in traumatic brain injury (31). 
Studies in humans showing improvements in blood flow 
to injured areas, as documented by serial single proton 
emission computed tomography scans, and changes in 
cerebral metabolism in patients with traumatic brain 
injury after HBO help to support this theory (30–33). 
The evidence is insufficient, however, to prove the 
effectiveness or ineffectiveness of HBO for traumatic 
brain injury, and other high-quality studies are needed 
(34). 
Cardiac ischemia 
Normobaric therapy has been in use for many years in 
the treatment of ischemic heart disease (35). When 
oxygen is breathed in concentrations higher than those 
found in the atmospheric air, it is considered to be a 
drug. A limited amount of oxygen is dissolved in blood at 
normal atmospheric pressure, but under hyperbaric 
conditions it is possible to dissolve sufficient oxygen, for 
example 6%, in plasma to meet the usual requirements 
of the body. The oxygen physically dissolved in solution 
will be utilized more readily than that bound to 
hemoglobin, and this effect may normalize or increase 
oxygen tension in ischemic tissue (35). 
The role of HBO in patients with acute myocardial 
infarction is debatable, ranging from no beneficial effect 
(36,37) to a favorable effect (38,39). The only controlled 
trial was completed by Thurston et al. (38) in the 
prethrombolytic area and revealed a trend, but not a 
statistically significant decrease, in mortality rates 
especially in high-risk patients. An animal study 
conducted by Thomas et al. (39) proved the hypothesis 
that a combination of thrombolytic therapy and HBO 
would be more effective in reducing the size of the 
myocardial infarction than either of these modalities 
alone. Therefore, a randomized pilot trial conducted by 
Shandling et al. (40) demonstrated that adjunctive 
treatment with HBO appears to be feasible and safe for 
patients in the acute phase of myocardial infarction. 
Finally, the Hyperbaric Oxygen and Thrombolysis in 
Myocardial Infarction study (41) demonstrated that 
treatment with HBO in combination with thrombolysis 
might result in an attenuated creatine phosphokinase 
rise, more rapid resolution of pain, and improved 
ejection fraction (42). 
The effect of hyperbaric oxygen therapy on the bout of 
treatment for soft tissue infections 
Tissue oxygen tensions are affected mainly by the 
concentration of inspired oxygen, cardiac output, local 
blood flow, cellular metabolism and substrate availability 
(43). Partial pressures of oxygen (PO2) are normally 
different in various body compartments. When the PO2 
in normal and infected tissues were measured with an 
oxygen microelectrode, dramatic decreases were found 
at the site of infection (44). A critical step in the killing of 
bacteria by polymorphonuclear neutrophils (PMN) is the 
production of H2O2; however, the ability of the PMN to 
produce H2O2 is decreased under anaerobic conditions 
(45). Hohn showed that the killing efficiency of human 
neutrophils for Staphylococcus Aureus was impaired by 
PO2 levels below 15 mmHg and severely decreased at 
levels from 5 to 0 mmHg (46). The decrease in tissue PO2 
from the normal 60 mmHg to less than 10 mmHg 
corresponds with the influx of leukocytes (44). The aim of 
HBO is to increase transported oxygen in the blood by 
increasing the physiologically dissolved oxygen. 
Furthermore, increased local PO2 is sufficient to 
influence bacterial killing by neutrophils and HBO has 
been shown to increase the killing ability of neutrophils 
(47–49). 
Studies have demonstrated that HBO therapy has 
bacteriostatic and bactericidal activity (50). Hyperoxia 
increases free-radical production and the increase of 
super oxide induced by HBO is toxic to both anaerobic 
and aerobic bacteria (43). Mader demonstrated that HBO 
alone was as effective as an antibiotic in the treatment of 
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experimental osteomyelitis due to Staphylococcus 
Aureus in rabbits (51). 
Additionally, HBO improves wound oxygenation so that 
host factors are able to control infection and function to 
heal the wound. Collagen synthesis in wounds is 
accelerated by exposure to moderate hyperoxia. Hunt 
showed the oxygen dependency of collagen production 
by fibroblasts (52). In another experimental study (53), 
HBO therapy has been shown to reduce skeletal muscle 
edema and necrosis in rat hind limb tourniquet ischemia, 
and in dog hind limb compartment syndrome models. In 
several mechanisms, HBO can enhance the effect of 
antibiotic therapy. In conclusion, HBO therapy combined 
with antibiotic therapy for soft tissue infections is 
recommended. 
There was also a clear clinical correlation between O2 
availability via a face mask and the development of 
wound infection. A study by Grief et al. (54) provided 
additional clinical evidence that enhancing wound O2 
levels through the administration of supplemental O2 
can improve the host’s immune responses. In their study 
of 500 patients undergoing abdominal surgery, all of 
whom received prophylactic antibiotics, administration 
of O2 at an 80% FiO2 during surgery and for 2 hours 
postoperatively resulted in a 5.2% wound infection rate 
versus an 11.2% infection rate in patients given O2 at a 
30% FiO2 (54). 
 
Treatment of acute carbon monoxide poisoning 
The guideline ‘Treatment of acute carbon monoxide 
poisoning’ from doctors in clinics with a tank for 
hyperbaric ventilation shows that carbon monoxide (CO) 
poisoning is a potentially life-threatening emergency. Its 
prognosis is linked to prompt recognition and treatment. 
CO is toxic because it binds to hemoglobin (Hb), thus 
impairing oxygen transport and causing tissue hypoxia. 
The most important symptoms are headache and altered 
consciousness, ranging from somnolence to coma. The 
diagnosis is based on a history of CO exposure combined 
with an elevated carboxyhemoglobin (HbCO) level in the 
blood. On the basis of the available literature, it is 
recommended that patients with an HbCO level > or = 
10% should always be treated. In patients requiring 
artificial ventilation, 100% oxygen for 8 hours is 
recommended. In pregnant women and in patients who 
are or have been comatose, hyperbaric oxygen can be 
considered. In all other symptomatic patients, use of a 
non-rebreathing mask with 100% oxygen for 8 hours is 
recommended (55). 
Recently, a large prospective study showed that 
hyperbaric oxygen improves the results of 
neuropsychological testing in all CO-poisoned patients, 
regardless of their consciousness level (56). In CO-
poisoned rats without loss of consciousness hyperbaric 
oxygen therapy was superior to normobaric oxygen in 
improving survival time, survival rate and reducing 
neurological morbidity (57,58). These acute effects of 
hyperbaric oxygen could be the result of reducing brain 
edema (57–58). 
Burns 
Hyperbaric oxygen therapy (HBO) can be used as an 
intervention for burns therapy. It was first suggested for 
the treatment of thermal burns more than 40 years ago 
when Wada et al. (59) serendipitously observed more 
rapid healing of second-degree burns in a group of coal 
miners who were being treated with HBO for carbon 
monoxide poisoning. In 1969, Gruber et al. (60) 
demonstrated that the area sub-adjacent to a full-
thickness injury was hypoxic and could be raised to 
normal or supra-normal levels through the 
administration of oxygen under pressure. This was 
followed by a series of animal experiments that 
demonstrated a significant reduction of edema, 
improved microcirculation, reduced inflammatory 
responses, faster epithelialization, and improved wound 
healing with HBO (61,62). 
The modest increase in tissue oxygen tension enables a 
raft of immune and healing functions in the hypoxic 
tissue. For example, the process of phagocytosis involves 
consumption of oxygen in an ‘oxidative burst’ and 
although such processes are possible at remarkably low 
tissue oxygen tensions, improving oxygenation to within 
or above the physiologic range dramatically improves the 
efficiency of such activity. Allen et al. (63) has shown that 
oxygen tensions between 40 and 80 mmHg are required 
to maintain activity at 50% of maximum in the NADPH-
linked oxygenase responsible for this respiratory burst. 
For it to work at 90% of maximum, oxygen tension of 400 
mmHg may be required (63). 
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In summary, while there is insufficient evidence to 
recommend routine HBO in the care of thermal burns, 
there appears to be a case for appropriate clinical 
investigation of this interesting treatment modality (64).  
Pain treatment 
Kiralp et al.’s study aimed to assess the effectiveness of 
hyperbaric oxygen (HBO) therapy for treating patients 
with complex regional pain syndrome. In the group that 
received 15 sessions of hyperbaric oxygen therapy there 
was a significant decrease in pain and edema and a 
significant increase in the range of motion. They 
concluded that HBO is an effective and well-tolerated 
method for decreasing pain and edema and increasing 
the range of motion in patients with complex regional 
pain syndrome (65). 
A review by Yidiz et al. (66) concluded that HBO may be 
beneficial if appropriate patients are selected for 
treatment of fibromyalgia syndrome (67), complex 
regional pain syndrome, myofascial pain syndrome, 
migraine, and cluster headaches (66). 
Other diseases treated with HBO 
There are a wide range of conditions where hyperbaric 
oxygen therapy is used in addition to traditional methods 
for treatment of other diseases. These include acute 
intoxications by psychotropic drugs (68), prevention of 
leakage from colonic anastomoses (69), treatment of 
infected free bone transplants (70), purpura fulminans 
(71), treatment for malabsorption in radiation-damaged 
short bowel (72), and in the treatment of nephrotic 
syndrome (73). In addition, it has been reported in the 
treatment of radiation injuries in gynecological cancers 
(74), for improving cardiac neural regulation in patients 
with diabetic autonomic dysfunction (75), for hepatic 
artery thrombosis following liver transplantation (76); as 
well as for necrotizing fasciitis (77,78), bacterial 
endocarditis (79), after microsurgical repair of transected 
peripheral nerves (80), and for managing pyoderma 
gangrenosum (81). More specific conditions include 
ischemic scleroderma wounds (82), radiation-induced 
proctopathy (83), bacterial brain abscesses (84), 
idiopathic sudden sensorineural hearing loss and tinnitus 
(85), cirrhosis (86), malignant otitis externa (87), 
lymphedema after breast cancer treatment (88), 
radiation-induced non-healing wounds (89), and Fournier 
gangrene (90) among other diseases. 
 
CONCLUSION 
This review has shown that if equipment for hyperbaric 
oxygen therapy is available, there are many patients who 
would benefit from treatment by this method. 
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